Your session is about to expire
← Back to Search
Anti-vaping and anti-smoking digital advertising for Tobacco Use(DMCC Trial)
DMCC Trial Summary
This trial will examine the effects of online anti-tobacco messages on young people's attitudes, beliefs, and behaviors related to tobacco use.
DMCC Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
DMCC Trial Design
Find a Location
Who is running the clinical trial?
- Group 1: Control
- Group 2: Digital intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I become a participant for this research project?
"The criteria for entry into this medical experiment require participants to have a history of tobacco use and be between 18-24 years old. A total of 2800 patients are being sought out by the study's research team."
Is enrollment for this trial still in progress?
"Online records from clinicaltrials.gov indicate that recruitment for this experiment is currently ongoing, having first been posted on February 20th 2021 and edited most recently on November 4th 2022."
Is the age criteria for enrollment into this research project restricted to those over seventy?
"The minimum age requirement for potential participants in this medical trial is 18 years old and the maximum age restriction is 24."
How many enrollees are accepted in this clinical trial?
"Indeed, according to clinicaltrials.gov's records, this medical trial is actively recruiting participants right now. It was first posted on February 20th 2021 and the most recent update occurred November 4th 2022; 2800 patients are being enrolled at a single location."
Share this study with friends